Adam Karpf
Affiliations: | Roswell Park - Pharmacology | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
Pharmacology, Molecular BiologyGoogle:
"Adam Karpf"Children
Sign in to add trainee| Shannon Morey Kinney | grad student | 2009 | SUNY Buffalo |
| Anna Woloszynska-Read | grad student | 2009 | SUNY Buffalo |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Jirapongwattana N, Bunting SF, Ronning DR, et al. (2024) RHNO1: at the crossroads of DNA replication stress, DNA repair, and cancer. Oncogene |
| Xu H, George E, Kinose Y, et al. (2021) copy number is a biomarker for response to combination WEE1-ATR inhibition in ovarian and endometrial cancer models. Cell Reports. Medicine. 2: 100394 |
| Liu C, Barger CJ, Karpf AR. (2021) FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer. Cancers. 13 |
| Barger CJ, Chee L, Albahrani M, et al. (2021) Co-regulation and function of / bidirectional genes in cancer. Elife. 10 |
| Kim O, Park EY, Klinkebiel DL, et al. (2020) In vivo modeling of metastatic human high-grade serous ovarian cancer in mice. Plos Genetics. 16: e1008808 |
| Zhang W, Klinkebiel D, Barger CJ, et al. (2020) Global DNA Hypomethylation in Epithelial Ovarian Cancer: Passive Demethylation and Association with Genomic Instability. Cancers. 12 |
| Haque M, Li J, Huang YH, et al. (2019) NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma. Cancers. 11 |
| Hillman JC, Pugacheva EM, Barger CJ, et al. (2019) BORIS expression in ovarian cancer precursor cells alters the CTCF cistrome and enhances invasiveness through GALNT14. Molecular Cancer Research : McR |
| Barger CJ, Branick C, Chee L, et al. (2019) Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer. Cancers. 11 |
| Sharma A, Albahrani M, Zhang W, et al. (2019) Epigenetic activation of POTE genes in ovarian cancer. Epigenetics |